Cadonilimab Plus Chemotherapy in PD-L1-Low Gastroesophageal Cancer: A Bispecific Opportunity?

Authors

• Sohiel Deshpande, Thomas Jefferson University HospitalFollow
• Daniel Lin, Thomas Jefferson UniversityFollow

Document Type

Editorial

Publication Date

8-27-2026

Comments

This article is the author's final published version in Journal of Gastrointestinal Oncology, Volume 17, Issue 4, 2026, Article number 281.

The published version is available at https://doi.org/10.21037/jgo-2026-0692. Copyright © AME Publishing Company.

Abstract

No abstract available.

Recommended Citation

Deshpande, Sohiel and Lin, Daniel, "Cadonilimab Plus Chemotherapy in PD-L1-Low Gastroesophageal Cancer: A Bispecific Opportunity?" (2026). Department of Medical Oncology Faculty Papers. Paper 353.
https://jdc.jefferson.edu/medoncfp/353

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

PubMed ID

42703328

Language

English